Stability of health-related quality of life and morbidity burden from 18 months after diagnosis of prostate cancer: results of a UK-wide population-based outcome cohort.

Samantha J MasonAmy DowningSarah WildingLuke HounsomePenny WrightEila WatsonRichard WaglandHugh ButcherPaul KindPeter SelbyAnna GavinAdam W Glaser

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)

The results suggest stability of HRQL and most specific morbidities by 18-42 months for men who report no further treatment in the subsequent 12 months. This is reassuring for those with good function and HRQL but re-enforces the need for early intervention and support for men who experience poor outcomes.

Keyphrases

prostate cancer
randomized controlled trial
middle aged
risk factors
adipose tissue
weight loss
replacement therapy
smoking cessation